camptothecin has been researched along with Nerve Degeneration in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kudo, W; Lee, HG; Lee, HP; Smith, MA; Zhu, X | 1 |
Friedman, WJ; Greene, LA; Park, DS; Stefanis, L | 1 |
Schreiber, SS; Tan, Z; Tu, W | 1 |
Ensor, EA; Kinloch, RA; Latchman, DS; Smith, MD | 1 |
4 other study(ies) available for camptothecin and Nerve Degeneration
Article | Year |
---|---|
Early induction of c-Myc is associated with neuronal cell death.
Topics: Amyloid beta-Peptides; Camptothecin; Cell Cycle; Cell Death; Cell Line, Tumor; Humans; Nerve Degeneration; Neurons; Proto-Oncogene Proteins c-myc; Transcriptional Activation | 2011 |
Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Caspase 2; Caspase Inhibitors; Caspases; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Cyclin-Dependent Kinases; Cytochrome c Group; Embryo, Mammalian; Enzyme Activation; Enzyme Inhibitors; Mitochondria; Nerve Degeneration; Neurons; Neuroprotective Agents; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteins; Rats | 1999 |
Downregulation of free ubiquitin: a novel mechanism of p53 stabilization and neuronal cell death.
Topics: Animals; Brain; Camptothecin; Cell Death; Cells, Cultured; DNA Damage; Down-Regulation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; In Situ Nick-End Labeling; Kainic Acid; Male; Nerve Degeneration; Neurons; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53; Ubiquitins | 2001 |
The POU domain transcription factor Brn-3a protects cortical neurons from apoptosis.
Topics: Animals; Animals, Newborn; Apoptosis; Camptothecin; Cell Survival; Cerebral Cortex; DNA-Binding Proteins; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Genetic Therapy; Genetic Vectors; Glutamic Acid; Green Fluorescent Proteins; Immunohistochemistry; Indicators and Reagents; Luminescent Proteins; Nerve Degeneration; Neurons; Neurotoxins; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Simplexvirus; Staurosporine; Transcription Factor Brn-3; Transcription Factors | 2001 |